Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
5
2019
USDA Testimony Sparks Debate Over Allowing Gene Editing for Food Labeled as Organic Keller and Heckman LLP
Aug
5
2019
Employment Law This Week®: Cannabis User Protections, WHD Opinion Letters, New Salary History Bans, NYS Anti-Harassment Training Deadline [VIDEO] Epstein Becker & Green, P.C.
Aug
4
2019
Pharmaceutical Importations Giordano, Halleran & Ciesla, P.C.
Aug
3
2019
Nordic Council of Ministers Publishes Report on Applicability of GHS Classification Criteria to Nanomaterials Bergeson & Campbell, P.C.
Aug
2
2019
Big Food Price-Fixing Update: Court Certifies Three Putative Classes in Packaged Seafood Litigation Bilzin Sumberg
Aug
2
2019
McDermottPlus Check-Up: August 2, 2019 McDermott Will & Emery
Aug
2
2019
A Look at the Food Handler Antiseptic OTC Rulemaking Keller and Heckman LLP
Aug
1
2019
FDA Adds Six New Substances to its Inventory of Effective FCS Notifications 2019 Keller and Heckman LLP
Aug
1
2019
Flies Are a Potential E. Coli Vector in Leafy Green Illness Outbreaks Keller and Heckman LLP
Aug
1
2019
Upcoming Legislation to Address Plastic Waste Keller and Heckman LLP
Jul
31
2019
Colorado’s New Psychiatric Advance Directive Process Goes Into Effect Aug. 2, 2019 Greenberg Traurig, LLP
Jul
31
2019
As War Over Plant-Based Food Labeling Wages On In The US, UK Sub-Committee Concludes Consumers Not Misled By Vegetarian “Burgers” Keller and Heckman LLP
Jul
30
2019
EC Committee Publishes Final Opinion on Solubility of Synthetic Amorphous Silica Bergeson & Campbell, P.C.
Jul
30
2019
Senate Finance Committee Passes Drug Pricing Bill Mintz
Jul
30
2019
FDA Exploring Additional Regulatory Pathways for CBD Products Keller and Heckman LLP
Jul
30
2019
Court Lets Trader Joe’s Out of Sticky Situation Over Honey Advertising Proskauer Rose LLP
Jul
29
2019
Delaware Supreme Court Allows Caremark Claim to Proceed Against Directors of Ice Cream Manufacturer Following Listeria Outbreak Sheppard, Mullin, Richter & Hampton LLP
Jul
29
2019
FDA Invites Compounding Outsourcing Facilities' Comments to Understand Industry Challenges and Opportunities Mintz
Jul
29
2019
ML Strategies Health Care Preview - Week of July 29, 2019 Mintz
Jul
29
2019
CBO Report Shows Senate’s Bipartisan Bill on Surprise Billing, Drug Prices, Transparency, and More Would Result in Deficit Decrease Sheppard, Mullin, Richter & Hampton LLP
Jul
29
2019
FDA Releases Fiscal Year 2020 Fee Rates and Reconfirms Policy of Not Invoicing for FSMA Food Facility Reinspection, Recall, and Importer Reinspection Fees Keller and Heckman LLP
Jul
29
2019
Senate Holds Public Hearing on Banking Access for the Cannabis Industry Steptoe & Johnson PLLC
Jul
29
2019
The Scotch Whisky Saga: Where Name And Reputation Is Not Enough K&L Gates
Jul
27
2019
International News in Chemical Policy and Regulation July 2019 Bergeson & Campbell, P.C.
Jul
27
2019
EPA Registers Long-Term Uses for Sulfoxaflor Bergeson & Campbell, P.C.
Jul
26
2019
New Jersey Expands Medical Marijuana Protections Proskauer Rose LLP
Jul
26
2019
Is Prescription Drug Pricing The Cure For Partisanship? Sheppard, Mullin, Richter & Hampton LLP
Jul
26
2019
Beyond Surprise Billing: Lower Health Care Costs Act of 2019 Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins